Trial Profile
Impact of IVUS-guided Chronic Total Occlusion Intervention With Drug-eluting Stents on Mid-term Angiographic and Clinical Outcomes
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2017
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Zotarolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions
- Acronyms CTO-IVUS
- 04 Apr 2012 New trial record